| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.009 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.0094 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0051 | 1 |